microbiological pattern in cases of preterm …
TRANSCRIPT
MICROBIOLOGICAL PATTERN
IN CASES OF PRETERM PREMATURE RUPTURE
OF FETAL MEMBRANES (PPROM)
BY
DR. JERRY OSA UWAIFO MBBS (BENIN)
SUBMITTED TO THE NATIONAL POSTGRADUATE MEDICAL
COLLEGE OF NIGERIA IN PART FULFILLMENT OF THE
REQUIREMENTS FOR THE
FELLOWSHIP OF THE COLLEGE
2007
i
ACKNOWLEDGEMENT
I wish to express my profound thanks to Professor A. U. Oronsaye for all
his assistance right from the beginning to the final stage of this work. I also give
special thanks to Dr M. E. Aziken who was never tired of correcting, advising
and directing me in doing this work in order to come out with a good paper.
Many thanks to Dr Daniel Ugbomoiko, the microbiologist who was so
committed in the laboratory to ensure that all samples collected were properly
analysed. I also thank the resident Doctors especially Dr Ebunum and the
nursing staffs of central Hospital, ST. Philomena Hospital and Faith Medical
Centre, Benin City for their contributions even with very minimal motivation.
Special thanks also go to my dear wife Mrs Abiodun Uwaifo, and my
children Jerry(Jnr), Stephany, Walter and Divine for their love and emotional
support.
I remain ever grateful to Deacon Uwadiae Uwaifo(M.B.E) and Mrs
Hannah Uwaifo, my parents of blessed memory for the legacy of education they
gave to me. I will always write their names in gold.
Finally, I thank God Almighty for his provisions, continuous Grace and
protection up to this time of my life.
ii
CENTRAL HOSPITAL
BENIN CITY
ETHICS AND RESEARCH COMMITTEE
CLEARANCE CERTIFICATE PROJECT TITLE: MICROBIOLOGICAL PATTERN IN CASES OF PRETERM
PREMATURE RUPTURE OF FETAL MEMBRANES (PPROM)
PRINCIPAL INVESTIGATOR: DR JERRY OSA UWAIFO
DEPARTMENT/ INSTITUTION: OBSTETRICS AND GYNAECOLOGY, CENTRAL
HOSPITAL, BENIN CITY.
DATE CONSIDERED: 23RD NOVEMBER 2006
DECISION OF THE COMMITTEE: APPROVED
CHAIRMAN:
DECLARATION BY INVESTIGATOR(S)
To be completed in four and three copies returned to the secretary, Ethics and Research
Committee, Clinical Services and training Division, Central Hospital, Benin City.
I/We fully understand the conditions under which I am/We are authorized to Conduct
the above mentioned research and I/We undertake to re-submit the protocol to the
Ethics and Research committee.
Signature………………………………….. Date…………………….
iii
CERTIFICATION
We hereby certify that this work was carried out by DR. JERRY OSA
UWAIFO of the Department of Obstetrics and Gynaecology, Central Hospital, Benin
City under our supervision.
Supervisors:
Professor A.U. Oronsaye (FRCOG, FMCOG, FWACS)
Consultant Obstetrician and Gynaecologist
Department of Obstetrics and Gynaecology
University of Benin Teaching Hospital, Benin City
Dr. M.E. Aziken (FWACS, FMCOG, FICS, MPH)
Consultant Obstetrician and Gynaecologist
Department of Obstetrics and Gynaecology
University of Benin Teaching Hospital, Benin City
iv
CONTENTS
Acknowledgement ……………………………………………………………….…i
Ethical Committee Certificate ……………………………………………………....ii
Certification………………………………………………………………………… iii
Contents…………………………………………………………………………….. iv
Abstract……………………………………………………………………………...1
Introduction…………………………………………………………………………. 2
Literature Review………………………………………………………………….. 4
Justification for study……………………………………………………………… .8
Aims and Objectives………………………………………………………………... 8
Hypothesis………………………………………………………………………….. 8
Materials and Methods……………………………………………………………… 9
Results………………………………………………………………………………11
Tables……………………………………………………………………………….12
Discussion…………………………………………………………………………..17
References…………………………………………………………………………..22
1
ABSTRACT
Preterm premature rupture of fetal membranes(PPROM) is a significant contributor to
poor obstetric outcome. The need for a continuous search for the aetiological factors to enable its
prevention and proper management if it occurs cannot be overemphasized.
This was a case control study (73 cases versus 73 controls with on going pregnancy
without rupture of membranes) aimed at determining the microbiological pattern of of PPROM
in our environment. Endocervical culture of cases and controls were compared. The cases of
PPROM had significantly more positive cultures than controls( 97.3% versus 5.5% ; p <0.001).
Escherischia coli(32.8%) was the commonest organism isolated. Other organisms of statistical
significance isolated include Proteus(21.9%), Bacteroides(15.1%), and Klebsiella(9.6%). These
organisms showed very good sensitivity to Ciprofloxacin(90.4%), Ceftriaxone(89%),
Ceftazidime(86.3%), Co-amoxiclav(80.8%), Erythromycin(73.9%), Cefuroxime(73.9%) and
Gentamicin(65.8%). Clindamycin(45.2%) only showed moderate sensitivity but Co-trimoxazole
Ampicillin, Amoxicillin and Cloxacillin all had low sensitivity.
A significant number of PPROM(58.9%) occurred at 31 – 33 weeks gestation(P. value
0.014). Low level of education or low socioeconomic class was significantly associated with
PPROM(82.2%, P <0.001)
A combination of Cefuroxime and Erythromycin given intravenously for the first 48
hours followed by oral combination of these two drugs for a further 5 days is suggested based on
the sensitivity pattern of the isolated organisms in this study. It is recommended that
prophylactic use of antibiotics in the management PPROM should be based on the
microbiological pattern and their sensitivity in any environment.
2
INTRODUCTION
Premature rupture of membranes (PROM) defined as rupture of fetal membranes before the onset
of labour, is a common obstetric event occurring in 10% of pregnancies1. Most of the time, this occurs at
or beyond 37 weeks gestation with only 10% of PROM occurring at less than 37 weeks gestation1, 2.
The natural course of preterm premature rupture of membranes (PPROM) is preterm labour and
this places the mother and fetus at increased risk of short term and long term morbidity and mortality.
Preterm delivery continues to occur in 5 – 10% of all births with a perinatal mortality rate of between
50% and 80%.2, 3, 4 PPROM is the most common identifiable cause present in 20 – 30%3.
The causes implicated in the multifactorial aetiology of PPROM include cervical incompetence,
lower genital tract infections, smoking, sexual intercourse, amniocentesis or other invasive prenatal
procedures. History of PROM in prior pregnancy and low placental insertion have also been linked with
PPROM 6,22,48.
In recent years, the role of infection with lower genital tract organisms in precipitating PPROM
and preterm labour has come under considerable study. Although the etiology of PPROM is
multifactorial,22, 38 increasing evidence regarding clinical risk factors, membrane histology, membrane
culture and amniotic fluid microbiology shows a strong association with infection4, 5, 6. Not only can
infection complicate PPROM but there is evidence that many organisms can penetrate intact fetal
membranes7, 8. Several studies indicate that women from the lower social class not only have a higher
incidence of PPROM, they are also more likely to develop chorioamnionitis as a complication of
PPROM9.
For women who develop PPROM before 34 weeks gestation, there is need for conservative
management to ensure fetal lung maturity. The major risk of conservative management of PPROM is
3
the development of maternal and fetal infection9, 18, 20, 22. Recommended management strategy include
use of corticosteroids, early tocolytic and antibiotics for known infections9, 10, 11. Early studies also
suggest that prophylactic antibiotics can be beneficial for women with idiopathic PPROM and preterm
labour. Such treatment offers a reduction of chorioamnionitis, prolongation of latency and a possible
reduction of neonatal infections and gestational age dependent morbidity in the setting of PPROM
remote from term.10, 11, 12, 18, 28 Amniotic fluid culture, culture of endocervical and high vaginal swabs
with the sensitivity pattern of isolated organisms in cases of PPROM are done in order to institute
appropriate antibiotic therapy.
Women from the lower socio-economic group have a markedly higher risk of preterm delivery
which is especially pronounced for PPROM. 9,15 This finding makes this study relevant in this
environment. In particular, the lack of laboratory support for the confirmation of clinical diagnosis in
many developing countries inevitably leads to the use of antibiotics inappropriately.23 Consequently,
there is a high potential for the abuse of antibiotics, a situation that currently poses serious public health
problems in many developing countries. Broadspectrum antibiotics are often prescribed in these
situations without microbiological studies. The dearth of microbiological studies in cases of PPROM
and the lack of good laboratory backup in our environment creates the need to study the microbiological
pattern and their sensitivities in order to rationally suggest a treatment regimen. Such treatment regimen
may become invaluable in health institutions where there are no laboratories.
4
LITERATURE REVIEW
Preterm delivery is currently the leading cause of perinatal morbidity and mortality and preterm
premature rupture of fetal membranes (PPROM) is the most common easily identifiable cause, present
in 20 – 30% of preterm births.3, 6 Although the etiology of PPROM is multifactorial,5, 26, 38 a wealth of
data is emerging linking subclinical genital tract infection with preterm birth and PPROM particularly
prior to 34 weeks gestation.2, 4, 5, 6 Conversely, preterm PROM and preterm birth that occurs closer to
term is less likely to be associated with genital tract infection.4
Lower genital tract organisms do not only contribute to the aetiology of PPROM, they cause
maternal and fetal infection and therefore account for the majority of perinatal mortality and morbidity
especially in the setting of PPROM occurring remote from term where conservative management have
to be employed8, 9, 12, 18, 37. Mothers who deliver prematurely have a higher incidence of endometritis46
and their infants have a higher incidence of neonatal infection.47 Graham et al37 showed that
conservative management resulted in a significant decrease in perinatal mortality and morbidity in an
American population. Improved understanding of the link between genital tract infection and preterm
birth now provides an exciting potential for the development of sensitive new markers to identify
women at risk and effective interventions to prevent preterm PROM/birth.
The patient with PPROM remote from term can benefit from conservative management where
the use of antibiotics and serial evaluation of maternal and fetal wellbeing, offer significant potential for
the reduction of perinatal mortality and morbidity.11, 12
Genital tract organisms have been found to penetrate intact fetal membranes8 and subsequently
result in PPROM through mechanisms that have been studied but not clearly understood26, 33. This
implies that intra-amniotic infection is often present before the occurrence of PPROM and it has been
5
estimated that at least one of every four cases of PPROM/preterm birth occur in the presence of intra-
amniotic or amniotic fluid infection7, 8, 39, 40.
The presence of periodontal disease has also been linked with PPROM and preterm births17. Oral
opportunistic pathogens and/or their inflammatory products may also have a role in preterm
birth/PPROM via a haematogenous route. Fusobacterium nucleate, a common oral species, is the most
frequently isolated species from amniotic fluid cultures among women with preterm labor and intact
membranes7, 17, 45.
Understanding the pathophysiologic mechanism by which genital tract infection leading to
PPROM is initiated will give us a better insight to the role of infections and so help tailor treatment in
order to reduce the perinatal mortality and morbidity associated with PPROM13. The identification of
several factors such as interleukin–1, neutrophil activating peptide–1/interleukin–8, and tumour necrosis
factor (TNF) in patients with idiopathic preterm labour/PPROM may allow us to determine the
pathophysiologic mechanism that lead to PPROM13, 17. However, an improved understanding of this
pathophysiologic mechanism remains one of the greatest challenges in obstetric care in this decade14.
Evidence of subclinical infection as a cause of preterm PROM and preterm labour is raised by
finding elevated maternal serum c-reactive protein and abnormal amniotic fluid organic acid levels in
some patients with preterm labour26. Biochemical mechanisms for preterm labour in the setting of
infection are suggested by both in vitro and in vivo studies of prostaglandins and their metabolites,
endotoxins and cytokines26, 33. The high concentration of potentially pathogenic microorganisms in the
vagina and cervix of pregnant women with bacterial vaginosis may increase the possibility of an
ascending infection via the cervix, decidua, fetal membranes, maternal placenta, and amniotic fluid33.
Some of the bacteria associated with bacterial vaginosis such as Bacteroides sp. are particularly
virulent. Certain bacteria produce enzymes that potentially could affect the fetal membranes or maternal
6
decidua. Bacteroides sp. and group B streptococcus produce proteases31,33,34,36. Protease enzymes
reduce the chorioamniotic membrane strength in vitro. It is even possible that a high concentration of
bacteria in the lower genital tract could produce enough proteases to weaken the fetal membrane
strength, causing premature rupture of the membranes. Bacterial lipases could also produce tissue
injury. Lysosomes within fetal membrane cells contain phospholipase A2 in high concentrations.
Phospholipase A2 is a precursor of prostaglandin synthesis and the destruction of lysosomes within
deciduae or chorioamnion cells may induce prostaglandin synthesis resulting in uterine contractions17, 22,
25, 33, 34.
In some studies, a high rate of phospholipase A2 production was found to be associated with
Bacteriodes sp, anaerobic Streptococci, Fusobacterium sp, and Gardnerrela Vaginalis. It was also
demonstrated that bacterial products of group B Streptococci, Viridans Streptococci, Escherichia Coli
and Bacteroides fragilis but not lactobacillus sp. increase the synthesis of prostaglandins in the
membranes33. Thus, selected bacteria, including some closely related to bacterial vaginosis may play a
role in the initiation of uterine contractions by stimulating prostaglandin synthesis26, 33, 34. In an
alternative mechanism, either the release of prostaglandin in the membrane or uterine contraction could
cause microbreaks of the membrane that allow bacterial colonization of the membrane33.
The microorganisms mostly associated with PPROM and preterm labour have been mentioned
above. Of all these organisms of bacterial vaginosis complex, group B Streptococci, E. coli, Bacteroides
sp, Viridans Streptococci and an unusual organism fusobacterium are frequently implicated12, 17, 24, 28, 31,
33, 40.
The Bacterial vaginosis complex include organisms such as Gardnerella Vaginalis, anaerobic
species primarily among Prevotella, Peptostreptococcus and Mobiluncus, Mycoplasma Hominis and
Ureaplasma Urealyticum17, 24, 28. It is interesting that candida sp, common in the vagina, is an unusual
7
pathogenic cause of preterm labour/PPROM7 and Haemophilus influenza has also been reportedly found
in women presenting with PPROM27.
The role of Chlamydia trachomatis and viruses in PPROM/preterm labour remains to be
determined28. Use of molecular microbiology techniques to diagnose intrauterine infection may uncover
the role of fastidious microorganisms that have not yet been discovered.
In a study in Saudi Arabia, Bahar et al found a variety of aerobic or anaerobic organisms or both
in cases of PPROM41. Shaarawy et al found Mycoplasma Hominis and Ureaplasma Urealyticum in
addition to aerobic and anaerobic bacteria in Egypt 42. This was similar to the findings of Abd EL
Kareim et al in another study in Egypt 44. In a study in Brazil, Silva et al isolated Staphylococcus aureus
in addition to a wide diversity of microorganisms 43. They found an intense inflammatory infiltrate in
the membranes which they linked to the rupture of membranes.
A search of the literature revealed that not much work has been done on this subject matter in our
local environment even though PPROM is often seen and management problems often arise. The need
to study the pattern in this environment cannot be over emphasized.
Antibiotic treatment for women with PPROM especially remote from term, offers significant
benefit with respect to pregnancy prolongation of the interval from rupture of membranes to delivery
and improvement in neonatal outcome19, 29, 30, 49 with reduced risk of maternal infection. The best
evidence supports the choice of an extended-spectrum agent or combination administered intravenously
for 2 days followed by an extended-spectrum or combination of oral agents for several days30. Despite
the effectiveness of antimicrobial therapy in this setting, the potential risk of systemic antibiotic
administration, such as allergic reactions, overgrowth of commersal organisms, and emergence of
resistant pathogens must always be kept in mind. Nevertheless, in the majority of cases, assuming the
8
patient is a good candidate for expectant management, the benefits of antibiotic therapy outweigh the
risk.
JUSTIFICATION FOR STUDY
Preterm premature rupture of fetal membranes is a significant cause of preterm
delivery which accounts for about 60% of perinatal mortality rate. Available evidence indicate
that genital tract infection contribute significantly to the aetiology of PPROM which in turn
predisposes to further infections. A combination of PPROM, Preterm delivery and Infections
would obviously worsen both maternal and fetal outcome.
In a low resource setting like Nigeria, there is need to be proactive in our
interventions to improve maternal and perinatal outcome in our practice.There is therefore need
to determine the microbiological pattern of infections and their sensitivities amongst patients
with PPROM in our environment.
AIMS AND OBJECTIVES 1. To determine the common microbial isolates in cases of PPROM.
2. To determine the antibiotic sensitivity pattern of these organisms.
3. To suggest from the findings, an antibiotic regimen in these cases that may be useful where
laboratory facilities are not available.
HYPOTHESIS
Patients with Preterm Premature Rupture of Membranes have significantly more
cultures of pathogenic organisms than patients matched for age and gestational age
without PPROM .
9
MATERIALS AND METHODS
This is a case control study conducted in the Department of Obstetrics and Gynaecology of the
Central Hospital, Benin City. This study included patients recruited from the antenatal clinics, antenatal
wards and labour wards of Central Hospital, St Philomina Hospital and Faith Medical Centre, Benin
City, with ruptured membranes before 37 weeks gestation and less than 24 hours duration of rupture of
membranes. The control group was made up of selected women from the antenatal clinic with on going
pregnancy without ruptured membranes matched for age(+ or - 3 years) and gestational age(+ or - 2
weeks) at 28 to 36 weeks gestation.
Patients excluded from this study include:
1. Those with ruptured membranes at less than 28 weeks or after 37 completed weeks
gestation.
2. Patients who have taken antibiotics within the past 7 days.
3. Patients with PPROM > 24 hours duration
4. Those with PPROM and temperature up to 380 C and above
5. Patients with PPROM and medical disorders e.g hypertension, diabetes mellitus, renal
disease etc.
The study comprised 73 patients with preterm premature rupture of membranes and 73
matched controls for age and gestational age without rupture of membranes. PPROM was
confirmed by pool of amniotic fluid in the vagina, its leakage through the cervix and/ or a
positive colour change of nitrazine stick from brown to deep blue. Endocervical swabs were
taken from all cases and from the control group in a similar manner. All samples were collected
personally by me and sent to the laboratory for microbiological studies. A well qualified
microbiologist handled and analysed all the samples collected at Central Hospital laboratory.
10
Each sample was innoculated immediately after collection into dried chocholate agar, two blood
agar, mac conkay agar and sabouraud dextrose agar. One of the blood agar plate was incubated
anaerobically using the anaerobic jar. They were all incubated at 37o C for 24-48 hours. Few
drops of saline were added to each swab after inoculation, put on a slide and examined
microscopically. Few drops of 10% Potassium Hydroxide(KOH) were also added separately to
specifically test for Gardnerella Vaginalis.(Whiff test).
Information on age, parity, gestational age, and level of education (socio-economic status)
were obtained from both cases and control.
Sample Size
The sample size for this study was calculated based on a PPROM incidence of 5% using the
formula by D.W. Taylor.
N = pq 0
(E/1.96)2
Where N = sample size
1.96 is a constant
p = known prevalence of the disease
q = 1 – p (proportion of persons free from the disease)
E = error margin allowable
N = 0.05 x 0.95 0
(0.05/1.96)2
= 72.998
73.
Ethical Consideration
Approval for this study was obtained from the ethical Committee of the Central Hospital, Benin
City.(see attached ethical committee certificate )
11
Also, the study was carefully explained to the patients and their informed consent obtained before
being recruited into the study. The rights of patients to participate or not was respected.
Data Management and Analysis
All information obtained were recorded on a data collection sheet designed for the study. The
results were first presented as percentages and further analysis was done in the computer using the Epi-
info programme. Chi square ( x 2) test and Fischers exact test where appropriate were used to test for
significant difference in observed proportion between the cases and controls.
P value < 0.05 was taken as significant.
RESULTS Seventy three(73) samples collected from cases of PPROM and controls respectively, making a total of
one hundred and forty six(146) samples were sent to the laboratory for microbiological analysis. Seventy one(71)
samples taken from cases of PPROM had positive cultures of various organisms. This gives a positive culture
rate of 97.3% ( P.value < 0.001** ). Only four(4) samples out of seventy three(73) taken from the control group
had positive cultures(5.5%).
An interesting finding in this study is that most of the cases of PPROM (82.2% , P. value < 0.001**)
occurred in women with no formal or primary education and this group largely belong to the lower socio-
economic class. Majority of the cases of PPROM (58.9%) occurred at 31 to 33 weeks gestation. Analysis of
these figures show they are statistically significant(**).
12
Table 1 : Socio Demographic Characteristics of the study Population
** Statistically Significant
Characteristics Case{N=73(%)} Control{N=73(%)} X2 P value P. value
Age
< 20
20 – 29
30 – 39
40
.
7 ( 9.59 )
40 ( 54.79 )
23 ( 31.51 )
3 ( 4.11 )
9 ( 12.32 )
35 ( 47.95 )
24 ( 32.88 )
5 ( 6.85 )
1.105
0.777
Parity
0
1
2-4
5
7 (9.59)
17(23.29)
46 (63.01)
3 (4.11)
12 ( 16.44 )
26 ( 35.62 )
30 ( 41.10 )
5 ( 6.88 )
7.068
0.070
Level of Education
No formal Educ
Primary Educ
Secondary Educ
Tertiary Educ
33 (45.21)
27 (36.99)
7 (9.59 )
6 (8.22 )
13 (19.17 )
16 (21.92 )
32 (43.84 )
11 (15.10)
27.99
<0.001**
Gestational Age
28 – 30
31 – 33
34 – 36
3 (4.11 )
43(58.90)
27(36.99)
12 (16.44)
29 (39.72)
32 (43.84)
8.546
0.014**
13
TABLE 11: FREQUENCY OF ISOLATION OF VARIOUS ORGANISMS
ORGANISMS
CASES
CONTROL
P. VALUE
N=73
%
N=73
%
Escherischia Coli
24
32.8 - - <0.001**
Staphylococcus aureus
6 8.2 2 2.7 0.275
RR=3
Proteus
16 21.9 - - <0.001**
Klebsiella
7 9.6 - - 0.013**
B-haemolytic strept
2 2.7 - - 0.497
RR=2
Streptococcus viridans
3 4.1 2 2.7 1.000
RR=1.5
Bacteroides
11 15.1 - - 0.001**
Haemophylus Influenza
2 2.7 - - 0.497
RR=2
Total positive culture
71 97.3 4 5.5 <0.001**
14
Candida albicans was isolated in 9(12.3%) of the cases but 20(27.4%) in the control group. P.value
0.037**(RR=0.5)
Gardnerella vaginalis was demonstrated microscopically and whiff test positive in 4(5.5%) cases of
PPROM but non in the control group. P. value 0.120(RR=3.5)
Trichomonas vaginalis was seen microscopically in 10(13.7%) cases of PPROM but 3(4.11%) in the
control group. P. value 0.078(RR=3.3)
These three occurred mixed with some of the positive bacterial cultures.
15
TABLE 111: SENSITIVITY PATTERN OF ISOLATES
Drug
NUMBER SENSITIVE AND PERCENTAGE
E. coli
24(%)
Proteus
16(%)
Staph
aureus
6(%)
Klebsiella
7(%)
B-haemo
Lytic strept.
2(%)
Strept.
Viridans
3(%)
Bacteroides
11(%)
Haemophy-
lus influenza
2(%)
Nil
culture
2(%)
Total
number
73
(100%)
COTR
12(50.0)
6(37.5) 2(33.3)
2(28.6) 1(50) 1(33.3)
2(18.2)
2(100) -
28(38.4)
AMP
4(16.7) 3(18.8) 1(16.7) 0 1(50) 1(33.3)
0
0 -
10(13.7)
CLOX
2(8.3) 0 4(66.7) 1(14.3) 1(50) 0
1(9.1)
1(50) -
9(12.3)
ERY
22(91.6) 12(75.0) 5(83.3) 5(71.4) 1(50) 1(33.3)
6(54.6)
2(100) -
54(73.9)
CIPR
23(95.8) 16(100) 5(83.3) 7(100) 1(50) 3(100)
9(81.8)
2(100) -
66(90.4)
AUG
20(83.3) 14(87.5) 6(100) 5(71.4) 2(100) 2(66.7)
8(72.7) 2(100) - 59(80.8)
CLIND
12(50.0) 6(37.5) 3(50.0) 3(42.9) 1(50) 1(33.3)
6(54.6) 1(50) - 33(45.2)
CEFTR
23(95.8) 12(75.0) 6(100) 7(100) 2(100) 3(100) 10(90.9) 2(100) - 65(89.0)
FORTU
24(100) 11(68.8) 6(100) 6(85.7) 2(100) 3(100) 9(81.8) 2(100) - 63(86.3)
GENT
22(91.7) 6(37.5) 5(83.3) 5(71.4) 2(100) 2(66.7) 5(45.5) 1(50) - 48(65.8)
CEXM
23(95.8) 5(31.3) 5(83.3) 6(85.7) 1(50) 3(100) 9(81.8) 2(100) - 54(73.9)
AMOX
11(45.8) 8(50.0) 2(33.3) 2(28.6) 1(50) 1(33.3) 2(18.2) 0 - 27(37.0)
16
COTX=Co-trimoxazole, AMP=Ampicillin, CLOX=Cloxacillin, ERY=Erythromycin, CIPR=Ciprofloxacin,
AUG=Augmentin(Co-amoxiclav), CLIND=Clindamycin, CEFTR=Ceftriaxone,
FORTU=Ceftazidime, GENT=Gentamicin, CEXM=Cefuroxime(zinacef/zinnat), AMOX=Amoxicillin.
TABLE 1
This shows the age distribution in the case and control groups to be homogenous. The mean ages were
26.7 and 27.0 years for cases and controls respectively. The study population consisted mainly of multiparous
women( 63 and 41.1 percent for cases and control respectively ). No statistically significant difference was
seen in age and parity between case and control( P. value 0.777 and 0.070 respectively ).
A significant number of the cases of PPROM (58.9%) occurred at 31-33 weeks gestation followed by
those that occurred between 34-36 weeks (37.0%). Only 4.1% occurred between 28-30 weeks gestation. This
shows that the occurrence of PPROM is significantly associated with gestational age group 31-33 weeks
(P.value 0.014**).
Low level of education( low socio-economic class ) which accounted for 82.2% was significantly
associated with PPROM in this study(P.value < 0.001).
TABLE 11
This shows the prevalence of various organisms isolated. There were seventy one(71) and four(4)
bacteriological isolates in case and control groups respectively. Escherischia Coli was the commonest organism,
accounting for 32.8%. The other organisms isolated include Proteus (21.9%), Bacteroides(15.1%), Klebsiella
(9.6%), Staphylococcus aureus(8.2%), and Streptococcus Viridans(4.1%). B-haemolytic Streptococcus and
Haemophylus influenza each accounted for 2.7%.
Total positive cultures were 97.3% and 5.5% for case and control respectively(P.value < 0.001**). The
occurrence of E.Coli, Proteus, Bacteroides and Klebsiella were statistically significant. Candida albicans was
isolated microscopically in 9(12.3%) of the cases but 20(27.4%) in the controls giving a P.value of 0.037 and
RR 0.5. Gardnerella Vaginalis was demonstrated microscopically and whiff test positive in four(4) of
17
the cases(5.5%) but non in the control group( P.value 0.120, RR 3.5 ).
Trichomonas Vaginalis was seen microscopically in ten(10) of the cases(13.7%) and three(3) in the control
group
(4.1%)[P.value 0.078, RR 3.3]. Candida albicans, Gardnerella Vaginalis and Trichomonas Vaginalis all occurred
along with some of the positive bacterial cultures in a mixed fashion.
TABLE 111
This shows the antibiotic sensitivity pattern of the organisms isolated. The drug that showed the
highest sensitivity was Ciprofloxacin(90.4%). This was followed by Ceftriaxone(89%),Ceftazidime (86.3%), and
Co-amoxiclav(80.8%). Others that showed good sensitivity were Erythromycin(74%), Cefuroxime (73%) and
Gentimicin(65.8%).
Clindamycin(45.2%), Co-trimoxazole(38.4%), Amoxicillin(37%), Ampicillin(13.7%) and Cloxacillin
(12.3%) all showed low effectiveness( sensitivity less than 50% ). The commonest pathogens isolated in this
Study; E.coli, Proteus, Bacteroides and klebsiella, showed good sensitivity to Ciprofloxacin, Ceftriaxone,
Ceftazidime, Erythromycin, Co-amoxiclav and Cefuroxime. Proteus was particularly not very sensitive to
Gentamicin(37.5%).
DISCUSSION
Preterm premature rupture of fetal membranes (PPROM) is the most common easily identifiable
cause of preterm labour accounting for 20-30% of preterm birth and this is currently the leading cause of
perinatal morbidity and mortality3,6. The occurrence of PPROM also put the mother at increased risk of
morbidity46. A wealth of data is emerging linking genital tract infection with PPROM/Preterm birth
particularly prior to 34 weeks gestation2,4,5,6.
This study of seventy three(73) cases of PPROM revealed a positive culture rate of 97.3%. This
statistically significant finding suggests a strong link of genital tract infections with the occurrence of PPROM.
A significant number of the cases occurred at 31-33 weeks gestation(P.value 0.014**). The reason for this is not
clear but a possible explanation may be that the vaginal flora is altered in these patients and this situation leads to
growth of pathogenic organisns which may ascend to gain assess to the endocervix and trigger the process
18
leading to amniorhexis/preterm birth. It is possible that the effect of this process is maximal at 31-33 weeks
gestation and therefore highest rate of rupture of membranes at this period of pregnancy.
Low level of education(82.3%) was significantly associated with PPROM in this study. Level of
education approximately correlates with socio-economic class and this was used in this study to measure this
factor. It can therefore be said that the occurrence of PPROM is strongly associated with low socio-economic
class(P.value <0.001). This agrees with findings of previous studies by Okonofua et al9, and Savitz D.A et al15.
The association of PPROM with low socio-economic class could be a reflection of the personal hygiene of
women in this environment.
E. Coli was the commonest organism isolated(32.8%). This gram negative aerobic and facultative
anaerobic organism has been found in previous studies to penetrate intact fetal membranes, cause intra-amniotic
infection and subsequently amniorhexis occurs8,26. Proteus(21.9%) and Klebsiella(9.6%)
found in this order of prevalence in this study are gram negative aerobes and facultative anaerobes but
Bacteroides(15.1%) is a gram negative anaerobic organism. They all belong to the Enterobacteriaceae group of
organisms. These findings are similar to those reported in previous works by Bahar et al41 and Abd El Kareim
et al44. Shaarawy et al42 found Mycoplasma Hominis and Ureaplasma Urealyticum in addition to aerobic and
anaerobic bacteria. Mycoplasma Hominis and Ureaplasma Urealyticum was not tested for in this study because
of non availability of the materials needed to isolate them. The isolation of Staphylococcus aureus(8.2%) in this
study is also similar to the findings of Silva et al43 in their study with the isolation of this organism along with
a wide diversity of aerobic and anaerobic organisms.The finding of an intense inflammatory infiltrate in the
membranes in their study was linked with the rupture of membranes as the aetiologic factor.The isolation of
Streptococcus Viridans(4.1%), B-haemolytic Streptococcus(2.7%) and Haemophylus Influenza(2.7%)though not
statistically significant in this study may be the other organisms that contribute to the wide variety of microbes
found in association with PPROM cases in previous studies27,41,42,43,44.
The microscopic isolation of Candida spp in 20 out of the 73 controls(27.4%) as against 9 in the cases
19
(12.3%) is worthy of note in this study. There appears to be an inverse relationship between the presence of
Candida spp and the occurrence of PPROM. This finding is at variance with that previously documented by
Chaim W et al7. Gardnerella Vaginalis demonstrated in 4 cases(5.5%) and non in the control group all occurred
in the cases where Bacteroides spp were isolated. This is worthy of note as this organism which is part of the
bacterial vaginosis complex is often associated with anaerobic bacteria such as Bacteroides and their role
in the aetiology of PPROM is already well documented31,33,36,51,52.
The sensitivity pattern in this study revealed that Ciprofloxacin had the highest sensitivity(90.4%) with
almost all the isolated organisms sensitive to it. However, this drug which is a quinolone is not safe in
pregnancy. Other drugs that showed excellent sensitivity include Ceftriaxone(89%), Ceftazidime(86.3%),
Co-amoxiclav(80.8%), Erythromycin(74%) and Cefuroxime(73%). Although some of these drugs
are expensive, they are safe in pregnancy and readily available. Co-amoxiclav has been found to cause neonatal
necrotising enterocolitis in the ORACLE trial 200153. The overall sensitivity of Gentamicin(65%) was good and
particularly very effective against the commonest pathogens; E.coli(91.7%) and Klebsiella(71.4%) but showed
poor effectiveness against Proteus(37.5%) and Bacteroides(45.5%). The common antibiotics used in our general
practice; Ampicillin, Co-trimoxazole, Cloxacillin and Amoxicillin all showed very low effectiveness against the
bacterial isolates in this study. Clindamycin showed moderate sensitivity only in the cases of Bacteroides and
E.coli. Ugwumadu et al(2004)54 reported that oral Clindamycin eradicated bacterial vaginosis and intermediate
flora in 90% of women prior to 20 weeks gestation. How effective this is, in cases of PPROM in our
environment remains to be determined in a study. Carey J.C et al55 however demonstrated the effectiveness
of Metronidazole in preventing preterm labour/PPROM in women with asymptomatic bacterial vaginosis.
Metronidazole is generally used empirically and known to be an effective drug against gram negative
anaerobic bacteria, Gardnerella Vaginalis and related organisms of the bacterial vaginosis complex.
Metronidazole sensitivity was not tested in this study as the disc was not available.
Two of the largest studies that looked at the efficacy of antibiotic use in PPROM are the National
Institute of Child Health and Human Development-Maternal Fetal Medicine Units (NICHD-MFMU) study
20
of PPROM56 and the ORACLE trial53. In the NICHD-MFMU study, intravenous antibiotics : Ampicillin 2gms
6hourly and Erythromycin 250mg 6hourly were used for 48 hours. The patients were then placed on
oral Amoxicillin 250mg 8hourly and enteric-coated Erythromycin-base 333mg every 8hours to complete a
7-day course of antibiotic therapy. In this trial, the antibiotic group had a significantly longer duration of
latency than the control group. The antibiotic group was twice as likely to remain undelivered after 7 days.
The increased latency continued for up to 3 weeks after discontinuation of antibiotics. Composite and
individual morbidities for the neonates were lower in the antibiotic group. Incidence of chorioamnionitis
and neonatal sepsis, including group B Streptococcal sepsis was decreased. In the ORACLE trial where
Co-amoxiclav was used either alone or in combination with erythromycin, an increased risk of necrotising
enterocolitis was present and there was no significant difference in latency and morbidity between the antibiotic
group and controls.
Based on current evidence, 7 days of antibiotics as proposed by the NICHD-MFMU study
is recommended for PPROM cases that are being managed conservatively. In this study in Benin city however,
the sensitivity of most of the bacterial isolates to Ampicillin was very poor(13.7%).The sensitivity to Ceftriaxone
(89%), Ceftazidime(86.3%), Cefuroxime(73%) and Erythromycin(74%) were excellent and any of
these can be substituted for Ampicillin. The effectiveness of Amoxicillin was also poor(37%). Of the three
cephalosporins found to be very effective in this study, Cefuroxime is readily available in parenteral and oral
forms and can be used to replace Ampicillin and Amoxicillin.
The regimen suggested based on findings in this study is intravenous Cefuroxime 1.5gms
8hourly and Erythromycin 250mg 8hourly for 48 hours. Then oral Cefuroxime 250mg 8hourly and
Erythromycin 250mg 8hourly to complete a 7-day course. It is also suggested that intravenous Metronidazole
500mg or Clindamycin 300mg be added 8hourly for 48hours, then oral Metronidazole 400mg 8hourly or
Clindamycin 150mg 8hourly for the remaining five days especially in cases where microscopy reveals the
presence of Gardnerella Vaginalis with other gram negative anaerobic organisms.
21
In conclusion, genital tract infection is significantly related to the occurrence of preterm premature
rupture of fetal membranes(PPROM) and it is one of the major aetiologic factors in our environment.
Escherischia Coli is the commonest micro-organism implicated in this study. Other organisms which are mainly
gram negative aerobes and anaerobes include Proteus, Klebsiella and Bacteroides. These are significantly
involved as aetiologic factors in the cases of PPROM. Low socio-economic class is a significant risk factor
demonstrated in this study. Antibiotics of significant sensitivity and of good prospect in the expectant
management of PPROM include Ceftriaxone, Ceftazidime, Cefuroxime, Erythromycin and Co-amoxiclav.
However, use of Co-amoxiclav is discouraged because of the neonatal necrotizing enterocolitis it causes. A
combination of these other drugs intravenously for the first 48 hours followed by oral administration of this
combination to complete a 7-day course is suggested based on findings of this study. This regimen can be used
for cases of PPROM in places where there are no good laboratory facilities or while awaiting results of
microscopy, culture and sensitivity.
Finally, it is observed that improvement of the general socioeconomic condition of women is likely
to have a significant impact on the reduction of PPROM/Preterm birth and subsequently a reduction of maternal
and perinatal mortality and morbidity.
22
REFERENCES
1. Alexander J.M, Cox S.M: Clinical Course of Premature Rupture of the Membranes. Semin
Perinatol 1996 Oct; 20(5): 369-74 (ISSN: 0146-0005).
2. Reynolds H.D.: Bacterial vaginosis and its implication in preterm labour and premature rupture
of membranes. A review of the literature. J. Nurse Midwifery 1991 Sept – Oct; 36(5): 289-96
(ISSN: 0091-2182).
3. Gazaway P, Mullins C.L: Prevention of Preterm labour and premature rupture of the membranes:
Clin Obstet Gynecol 1986 Dec; 29(4): 835-49 (ISSN: 0009-9201).
4. Andrews W.W; Goldenberg R.L; Hauth J.C: Preterm labour – emerging role of genital tract
infections. Infect Agents Dis 1995 Dec; 4(4): 196-211 (ISSN: 1056-2044).
5. Beazley D; Lewis R: The evaluation of infection and pulmonary maturity in women with
premature rupture of membranes. Semin Perinatol 1996 Oct; 20(5): 409-17 (ISSN: 0146-0005).
6. Minkoff H: Prematurity – Infection as an aetiologic factor. Obstet Gynecol 1983 Aug; 62(2): 137
– 44 (ISSN: 0029-7844).
7. Chaim W; Mazor M; Wiznitzer A: The prevalence and clinical significance of intra-amniotic
infection with candida species in women with preterm labour. Arc Gynecol Obstet 1992; 251(1):
9-15 (ISSN: 0932-0067).
8. Miller et al, 1980; Galask et al 1984: Preterm labour: In Dewhurst Textbook of Obstetrics &
Gynaecology for Postgraduates. Blackwell Sciences Ltd. 5th Edition, pp 483 – 484.
9. Okonofua, F.E.; Onwudiegwu, U. and Odunsi, A.: Preterm premature rupture of fetal membranes
in a low socio-economic population: results of conservative management: In. J. Gynecol, Obstet.,
1990, 34:35 – 39.
10. Gjerdingen D.K: Premature labour, Part II: Management: J. Am Board Fam pract 1992 Nov –
Dec; 5(6): 601-15 (ISSN 0893-8652).
11. Mercer B.M; Lewis, R: Preterm labour and preterm premature rupture of membranes. Diagnosis
and Management: Infect. Dis Clin North Am 1997 March; 11 (1): 177 – 201 (ISSN: 0891 –
5520).
12. Mercer B.M: Management of preterm premature rupture of membranes: Clin. Obstet Gynecol
1998 Dec; 41(4) 870 – 82 (ISSN: 0009 – 9201).
13. Asract T; Garite T.J: Management of preterm premature rupture of membranes: Clin Obstet
Gynecol 1991 Dec; 34(4): 730 – 4 (ISSN: 0009 – 9201).
23
14. Bocking A.D: Preterm labour: recent advances in understanding of pathophysiology, diagnosis
and management: Curr Opin Obstet Gynecol 1988 Apr; 10(2): 151 – 6 (ISSN: 1040 – 872X).
15. Savitz D.A; Blackmore C.A; Thorp J.M: Epidemiologic characteristics of preterm delivery:
etiologic heterogeneity. Am J Obstet Gynecol 1991 Feb; 164(2): 467 – 71 (ISSN: 0002 – 9378).
16. Malee M.P: Expectant and active management of preterm premature rupture of membranes –
Obstet Gynaecol Clin North Am 1992 Jun; 19(2): 309 – 15 (ISSN: 0889 – 8545).
17. Hill G.B: Preterm birth: associations with genital and possibly oral microflora. Ann Periodontol
1998 Jul; 3(1): 222 – 32.
18. Mercer B.M: Preterm premature rupture of membranes. Obstet Gynecol 2003 Jan; 101(1) 178 –
93 (ISSN: 0029 – 7844).
19. Lamont R.F: The prevention of preterm birth with the use of antibiotics: Eur J Pediatr 1999 Dec;
158 Suppl 1:52 – 4 (ISSN: 0340 – 6199).
20. Reimer T; Ulfig N; Friese K: Antibiotics-treatment of preterm labour. J. Perinat Med 1999;
27(1): 35 – 40 (ISSN: 0300-5577).
21. Carroll S; Sebire N; Nicolaides K: Preterm pre-labour amniorrhexis. Curr Opin Obstet Gynecol
1996 Dec; 8(6): 441 – 8 (ISSN: 1040 – 872X).
22. Kelly T: The pathophysiology of premature rupture of the membranes. Curr Opin Obstet Gynecol
1995 Apr, 7(2): 140 – 5 (ISSN: 1040 – 872X).
23. Okonofua, F.E: The Use of Antibiotics in Obstetrics and Gynaecology. Tropical Journal of
Obstetrics and Gynaecology Vol. 12 Suppl. 1 – 1995.
24. Gravett M.G; Eschenbach D.A: Possible role of ureaplasma urealyticum in preterm premature
rupture of the fetal membranes. Pediatr Infect Dis 1986 Nov – Dec; 5(6 Suppl): S 253-7 (ISSN:
0277 – 9730).
25. Gomez R; Romero R; Edwin S.S; David C: Pathogenesis of preterm labour and preterm
premature rupture of membranes associated with intra-amniotic infection: Infect Dis Clin North
Am 1997 Mar, 11(1): 135 – 76 (ISSN: 0891 – 5520).
26. Gibbs R.S; Romero R, Hillier S.L; Eschenbach D.A; Sweet R.: A review of premature birth and
subclinical infection. Am J Obstet Gynecol 1992 May; 166(5): 1515 – 28 (ISSN: 0002 – 9378).
27. Mazor M; Chaim W; Maymon E: Intra-amniotic infection with haemophilus influenzae. Report
of a case and review of the literature. Arch Gynecol Obstet 1991; 249(1): 47 – 50 (ISSN: 0932 –
0067).
24
28. Goncalves L.F; Chaiworapongsa T; Romero R: Intrauterine infection and prematurity. Ment
Retard Dev Disabil Res Rev 2002; 8(1): 3 – 13 (ISSN: 1080 – 4013).
29. Kirschbaum T: Antibiotics in the treatment of pre-term labour. Am J. Obstet Gynecol 1993 April;
168(4): 1239 – 46 (ISSN: 0002 – 9378).
30. Locksmith G.J: Antibiotic therapy in preterm premature rupture of membranes. Clin Obstet
Gynecol 1998 Dec; 41(4): 864 – 9 (ISSN: 0009 – 9201).
31. McGregor J.A; French J.I; Seok: Premature rupture of membranes and bacterial vaginosis. Am J.
Obstet Gynecol 1993 Aug; 169(2 pt 2): 463 – 6 (ISSN: 0002 – 9378).
32. Gibbs R.S; Eschenbach D.A: Use of antibiotics to prevent preterm birth. Am. J Obstet Gynecol
1997 Aug; 177(2): 375 – 80 (ISSN: 0002 – 9378).
33. Martins J; Eschenbach D.A: The role of bacterial vaginosis as a cause of amniotic fluid infection,
chorioamnionitis and prematurity – a review. Arch Gynecol Obstet 1990; 247(1): 1 – 13 (ISSN:
0932 – 0067).
34. Goldenberg R.L; Andrews W.W; Hauth J.C: Choriodecidual infection and pre-term birth. Nutr
Rev 2002 May; 60(5 pt 2): S 19 – 25 (ISSN: 0029 – 6643).
35. Besinger R.E: Preterm labour, premature rupture of membranes, and cervical incompetence. Curr
Opin Obstet Gynecol 1993 Feb; 5(1): 33 – 9 (ISSN: 1040 – 872X).
36. Kingsley C. Anukam; Emmanuel O. Osazuwa; Ijeoma Ahonkhai and Gregor Reid: Association
between absence of vaginal lactobacilli PCR product and nugent scores interpreted as bacterial
vaginosis. Tropical J. Obstet Gynecol, 22(2) October 2005.
37. Graham L.R; Gilstrap L.C; Hauth J.C; Kodack-Garza S; Conaster D.G: Conservative
management of patients with premature rupture of fetal membranes. Obstet Gynecol 59:607,
1982.
38. Shubert P.J; Dis E; Iams J.D: Etiology of preterm premature rupture of membranes. Obstet
Gynecol Clin North Am 1992 Jun; 19(2): 251 – 63 (ISSN: 0889 – 8545).
39. Miller J.M; Pupkia M & Hill G.B. (1980): Bacterial Colonisation of amniotic fluid from intact
fetal membranes. Am J. Obstet Gynecol 136, 796 – 804.
40. Chaim W; Mazor M.: Intra-amniotic infection with fusobacteria. Arch Gynecol Obstet 1992;
251(1): 1 – 7.
41. Bahar AM, Bilal N, Eskander MA: High Vaginal swab Cultures in normal and preterm labor.
International journal of Gynaecology and Obstetrics 2004; 87 : 145 – 146.
25
42. Shaarawy M, El – Minawi AM: Prolactin and Calcitropic hormones in preterm premature rupture
of membranes. International journal of Gynaecology and Obstetrics. 2004 Mar; 84(3): 200 – 207
43. Silva MG, Peracoli JC, Sadatsune T, Abreu ES, Peracoli MT: Cervical Lactobacillus and
leukocyte infiltration in preterm premature rupture of membranes. International journal of
Gynecology and Obstetrics. 2003 May; 81(2): 175 – 182.
44. Abd El Kareim M, El Gazzar Am, Afifi MA, El Shaer MM: Vaginal microbiology and
spontaneous preterm labour. Egyptian Society of Obstetrics and Gynecology. 2000 Jan – Mar;
26(1-3) : 81 – 92.
45. Romero R., Sirtori M., Oyarzun E, et al (1989). Infection and labor, microbiology and clinical
significance of intra-amniotic infection in women with preterm labor and intact membranes. Am
J Obstet Gynecol 161, 817 – 24.
46. Daikoku N.H; Kaltreider F; Khouzami V.A.; Spence M. & Johnson W.C. (1982). Premature
rupture of membranes and spontaneous preterm labour. Maternal endometritis risks. Obstet
Gynecol 59, 13 – 20.
47. Westgren M. (1985): Spontaneous premature rupture of membranes and fetal/neonatal infections.
In: Beard R.W. & Sharp F. (eds) preterm labour and its consequences. London Royal College
Obstetricians and Gynaecologists, pp. 149 – 54.
48. Kaye D: Risk factors for preterm premature rupture of membranes at mulago hospital, kampala.
East African Medical Journal. 2001 Feb; 78(2) : 65 – 9.
49. Parvez T, Hamid F: The study of maternal morbidity and amnionitis with respect to premature
rupture of membranes. JK – Practitioner 2001 July – Sep; 8(3) : 159 – 160.
50. Taylor D.W. 1994: The calculation of sample size and power in the planning of experiments:
Department of Clinical Epidermiology and Biostatistics Mc Master University, Hamilton,
Ontario Canada.
51. Nugent R. P, Krohn M.. A, Hillier S.L : Reliability of diagnosing bacterial vaginosis by a
standardized method of gram stain interpretation. J. clin microbiol 29:297, 1991.
52. Klebanoff M.A, Hauth J.C, MacPherson C,A, et al : Time course of the regression of
asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J. Obstet
Gynecol 190:363, 2004a.
53. Kenyon S.L, Taylor D.J, Tarnow-Mordi W, et al: Broadspectrum antibiotics for preterm
prelabour rupture of fetal membranes: The ORACLE 1 randomized trial, Lancet 357:979, 2001a.
54. Ugwumadu A, Reid F, Hay P, et al: Natural history of bacterial vaginosis and intermediate flora
in pregnancy and effect of oral clindamycin. Obstet Gynecol 104:114, 2004.
26
55. Carey J. C, Klebanoff M. A, Hauth J. C, et al : Metronidazole to prevent preterm delivery in
pregnant women with asymptomatic bacterial vaginosis. N Engl J Med 342:534, 2000.
56. National Institute of Child Health and Human Development-Maternal Fetal Medicine
Unit(NICHD-MFMU) study : The efficacy of antibiotic use in PPROM. In Williams Textbook of
Obstetrics, 22nd edition, pp 866-867.